Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raúl D. Santos(Universidade de São Paulo), Shizuya Yamashita(NTT WEST Osaka Hospital), Kausik K. Ray(Imperial College London), Philip J. Barter(The Heart Research Institute), Ann S Jackson(Louisville Metabolic and Atherosclerosis Research Center), Jacques Genest(McGill University Health Centre), Mariko Harada‐Shiba(Osaka University of Pharmaceutical Sciences), Khalid Al‐Rasadi(Sultan Qaboos University Hospital), Robert A. Hegele(Western University), Marina Cuchel(University of Pennsylvania), Frederick J. Raal(University of the Witwatersrand), Tomáš Freiberger(Masaryk University), M. John Chapman(University of Cambridge), Steve E. Humphries(University College London), Joep C. Defesche(Academic Medical Center), Zelijko Reiner(Agency for Mobility and EU Programmes), Samuel S. Gidding(Genomic Health (United States)), Gerald F. Watts(Royal Perth Hospital), Seth J. Baum(Boca Raton Regional Hospital), Eric J.G. Sijbrands(Erasmus MC), Alberico L. Catapano(University of Milan), G. Kees Hovingh(Academic Medical Center), Emanuela Folco(European Society of Hypertension), Pedro Mata(Hispanics in Philanthropy), Patrick M. Moriarty(University of Kansas Medical Center)
Cited by 418
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k